SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-025161
Filing Date
2022-10-31
Accepted
2022-10-31 15:58:19
Documents
14
Period of Report
2022-10-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K blgo20221031_8k.htm   iXBRL 8-K 29149
2 EXHIBIT 99.1 ex_439873.htm EX-99.1 12940
  Complete submission text file 0001437749-22-025161.txt   174856

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blgo-20221026.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blgo-20221026_def.xml EX-101.DEF 11161
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blgo-20221026_lab.xml EX-101.LAB 14899
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blgo-20221026_pre.xml EX-101.PRE 11262
8 EXTRACTED XBRL INSTANCE DOCUMENT blgo20221031_8k_htm.xml XML 2460
Mailing Address 14921 CHESTNUT ST. WESTMINSTER CA 92683
Business Address 14921 CHESTNUT ST. WESTMINSTER CA 92683 888 400-2863
BIOLARGO, INC. (Filer) CIK: 0000880242 (see all company filings)

IRS No.: 650159115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19709 | Film No.: 221345897
SIC: 2800 Chemicals & Allied Products